European contribution to the science, prevention and management of HIV infection.
The objectives of the European Commission Biomed AIDS Programme are to enable Europe to pool its intellectual and financial resources in the control, treatment and prevention of HIV infection and AIDS. In order to facilitate this aim the Commission has allocated 40 to 50 million ECU over the past 6 years for concerted action of the Biomed projects on AIDS by the countries of the European Union. This is only a small proportion of the real cost spent by the member countries on this epidemic.
Lehner
T
T
Department of Immunology, United Medical School, Guy's Hospital, London, UK.
Biberfeld
P
P
Boucher
C
C
Darbyshire
J
J
Fenyö
E M
EM
Heeney
J L
JL
Jager
J C
JC
Lundgren
J D
JD
Newell
M L
ML
Rösch
P
P
Rossi
P
P
Virelizier
J L
JL
D016915:AIDS Vaccines; D000163:Acquired Immunodeficiency Syndrome / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D005060:Europe; D015658:HIV Infections / Q000453:epidemiology / Q000628:therapy* / Q000821:virology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn
D016915:AIDS Vaccines